Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
Aurigene, billing, Cambridge, CNS, Connecticut, dollar, Euro, frame, half, incorrectly, low, mg, molecule, preclinical, remeasured, Remeasurement, spot, sthe, thereunder, UCPA, undisclosed, upfront, Utah, VCDPA, VDCPA
Removed:
CMO, commenced, epidemic, Refer, reluctance
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view